1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Chen Xiaoping: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models HAIC + Tislelizumab +lenvatinib - HCC, Precision Therapy | Phase 1 | Unknown | Chen Xiaoping | 30 | 2024-06-01 | 2024-06-17 |
China (1)
WanGuang Zhang (1)